Alfred M. Cohen

Q: What Schools Are Affiliated With Alfred M. Cohen

Alfred M. Cohen is affiliated with the following schools: University of Amsterdam, Duke University

Alfred M. Cohen's AcademicInfluence.com Rankings

Alfred M. Cohen

Medical

#2858

World Rank

#3300

Historical Rank

Oncology

#187

World Rank

#193

Historical Rank

medical Degrees

Download Badge

Medical

Alfred M. Cohen's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Alfred M. Cohen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alfred M. Cohen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. (2004) (1332)
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. (1999) (865)
Liver resection for colorectal metastases. (1997) (848)
Patterns of recurrence of rectal cancer after potentially curative surgery (1983) (529)
Influence of hospital procedure volume on outcomes following surgery for colon cancer. (2000) (486)
Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. (1996) (417)
Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. (1996) (406)
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. (2003) (390)
Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal Cancer (2005) (373)
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. (2002) (350)
Long-Term Results of Local Excision for Rectal Cancer (2002) (322)
Neuroendocrine Carcinomas of the Colon and Rectum (2004) (316)
Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. (1999) (301)
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. (2003) (280)
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. (1999) (276)
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. (1999) (271)
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. (1992) (266)
Long-Term Prognostic Significance of Extent of Rectal Cancer Response to Preoperative Radiation and Chemotherapy (2002) (264)
Failure Patterns Following Curative Resection of Colonic Carcinoma (1984) (252)
Rectus Flap Reconstruction Decreases Perineal Wound Complications After Pelvic Chemoradiation and Surgery: A Cohort Study (2005) (248)
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer (1997) (246)
Variables correlated with the risk of lymph node metastasis in early rectal cancer (1992) (245)
Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. (1998) (232)
Adequacy of 1-cm Distal Margin After Restorative Rectal Cancer Resection With Sharp Mesorectal Excision and Preoperative Combined-Modality Therapy (2003) (222)
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer (1992) (221)
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. (1992) (206)
Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. (1995) (198)
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. (1996) (196)
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. (1994) (195)
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. (1997) (191)
Treatment of Rectal Cancer by Low Anterior Resection with Coloanal Anastomosis (1994) (190)
Prognosis of node‐positive colon cancer (1991) (171)
Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. (1995) (170)
Surgical Salvage of Recurrent Rectal Cancer After Transanal Excision (2005) (167)
Long-term functional results of coloanal anastomosis for rectal cancer. (1994) (165)
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography (2000) (164)
T1 Adenocarcinoma of the Rectum: Transanal Excision or Radical Surgery? (2005) (161)
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. (2001) (159)
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. (1994) (156)
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. (2002) (156)
Treatment of colorectal cancer: hepatic metastasis. (1996) (155)
Adjuvant therapy for colorectal cancer. (1997) (153)
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. (2005) (152)
Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas (1983) (152)
Surgical Salvage of Recurrent Rectal Carcinoma After Curative Resection: a 10-Year Experience (1999) (143)
Repeat Hepatic Resections for Metastatic Colorectal Cancer (1994) (142)
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. (2005) (141)
All patients with small intramural rectal cancers are at risk for lymph node metastasis (1999) (138)
p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. (1994) (137)
Surgical treatment of colorectal metastases to the liver (1995) (133)
Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. (1997) (133)
Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer (2001) (131)
Postoperative radiation therapy of rectal cancer. (1987) (131)
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. (1998) (131)
Operative Salvage for Locoregional Recurrent Colon Cancer After Curative Resection: An Analysis of 100 Cases (2005) (131)
Preoperative 5‐fluorouracil, low‐dose leucovorin, and concurrent radiation therapy for rectal cancer (1994) (130)
Cancer of the colon, rectum, and anus (1995) (129)
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. (1990) (123)
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. (2000) (121)
Predictors of Survival in Recurrent Rectal Cancer After Resection and Intraoperative Radiotherapy (2002) (121)
Sacral Resection for Recurrent Rectal Cancer: Analysis of Morbidity and Treatment Results (2006) (121)
Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid (1985) (114)
Abdominoperineal resection for rectal cancer at a specialty center (2001) (113)
Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers (2002) (113)
Complications of intraoperative radiation therapy. (1984) (109)
T3N0 rectal cancer: Results following sharp mesorectal excision and no adjuvant therapy (1999) (107)
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. (1999) (106)
Stage I rectal cancer: identification of high-risk patients. (1998) (103)
Iodine‐125 implant and external beam irradiation in patients with localized pancreatic carcinoma. A comparative study to surgical resection (1980) (103)
Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. (1991) (102)
The efficacy of preoperative 5‐fluorouracil, high‐dose leucovorin, and sequential radiation therapy for unresectable rectal cancer (1993) (102)
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update (1994) (99)
Peritoneal seeding following potentially curative resection of colonic carcinoma: Implications for adjuvant therapy (1991) (99)
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. (1997) (99)
Cancer pain relieved by long-term epidural morphine with permanent indwelling systems for self-administration. (1981) (96)
Intraoperative irradiation for unresectable pancreatic carcinoma (1982) (93)
Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer (2003) (93)
Preoperative high‐dose leucovorin/5‐fluorouracil and radiation therapy for unresectable rectal cancer (1991) (90)
Prokinetic effect of erythromycin after colorectal surgery (2000) (89)
KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer (2010) (89)
Surgical Management of Isolated Retroperitoneal Recurrences of Colorectal Carcinoma (2002) (87)
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. (1992) (87)
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. (2006) (86)
Pathological studies in rectal cancer (1980) (85)
Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older (2000) (84)
Regional hepatic chemotherapy using an implantable drug infusion pump. (1983) (83)
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. (1996) (80)
Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation (2000) (78)
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. (2005) (78)
Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. (1992) (76)
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. (1993) (74)
7. Obstructive and Perforative Colonic Carcinoma: Patterns of Failure (1985) (74)
Local failure following curative resection of colonic adenocarcinoma. (1984) (73)
Pancreatic or duodenal resection or both for advanced carcinoma of the right colon (2000) (72)
Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients (1993) (72)
Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients (1997) (70)
Residual, inoperable or recurrent colorectal cancer. Interaction of surgery and radiotherapy. (1980) (69)
Local Excision and Postoperative Radiation Therapy for Rectal Cancer (1994) (69)
Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. (1999) (69)
Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. (1992) (65)
Lymph node micrometastases do not predict relapse in stage II colon cancer (2000) (64)
NCCN Practice Guidelines for Colorectal Cancer. (2000) (62)
Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer. (1986) (60)
Aggressive surgical management of locally advanced primary and recurrent rectal cancer (1990) (59)
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. (1993) (59)
Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma (1990) (57)
A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases (1993) (57)
Anorectal disease in neutropenic leukemic patients (1994) (56)
Signet-ring cell carcinoma of the colon and rectum: a matched control study. (1998) (55)
Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer (2018) (54)
Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer (1992) (53)
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy (2003) (53)
Evaluation of Preoperative and Postoperative Radiotherapy on Long-Term Functional Results of Straight Coloanal Anastomosis (2003) (52)
Radiation therapy for unresectable rectal cancer. (1991) (52)
Single chain antigen binding protein (sFv CC49) (1997) (51)
Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump (1983) (51)
Signet-ring cell carcinoma of the colon and rectum (1999) (51)
Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy. (1987) (50)
Screening asymptomatic patients at high risk for colon cancer with full colonoscopy (1987) (49)
Intraoperative parasympathetic nerve stimulation with tumescence monitoring during total mesorectal excision for rectal cancer. (2002) (48)
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. (2002) (47)
Urinary Diversion After Total Pelvic Exenteration for Rectal Cancer (1999) (47)
Abdominal wall recurrence after colorectal resection for cancer (2000) (47)
Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. (1980) (46)
Sphincter preservation in rectal cancer by local excision and postoperative radiation therapy (1991) (46)
Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy. (2004) (45)
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined‐modality therapy (1999) (45)
Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. (1984) (45)
High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. (1994) (43)
Salvage therapy for pelvic recurrence following curative rectal cancer resection (1997) (42)
Surgeons as an Integral Part of the Cancer Research Team (2003) (42)
Resection of Locally Recurrent Colorectal Cancer in the Presence of Distant Metastases: Can It Be Justified? (2003) (42)
Varying features of early age-of-onset “Sporadic” and hereditary nonpolyposis colorectal cancer patients (1999) (41)
Studies of dormant tumor cells (1971) (40)
Differential expression of protein kinase C isoforms in human colorectal cancers. (1995) (39)
Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. (1980) (37)
Surgical treatment of colorectal cancer (1997) (37)
Transrectal ultrasonography of rectal carcinoma (1990) (36)
Early discharge after modified radical mastectomy. (1986) (35)
Current issues in colorectal cancer surgery. (1999) (34)
Radiation and conservative surgery in the treatment of soft tissue sarcoma. (1984) (33)
Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection rates (2001) (33)
Selective use of adjuvant radiation therapy in resectable colorectal adenocarcinoma (1981) (32)
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial (2016) (32)
Conservative management of anal leiomyosarcoma (1991) (31)
Metabolic response to three years of continuous, basal rate intravenous insulin infusion in type II diabetic patients. (1985) (31)
Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy (1986) (30)
Minimizing the toxicity of pelvic radiation therapy in rectal cancer. (1988) (30)
Facilitated metastatic distribution of the Walker 256 tumor in sprague‐dawley rats with hydrocortisone and/or cyclophosphamide (1970) (27)
Obstructive and perforative colonic carcinoma: patterns of failure. (1985) (27)
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. (2020) (26)
Obstructive and perforative colonic carcinoma: Patterns of failure (1984) (26)
Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen. (1994) (26)
Transbrachial hepatic arterial chemotherapy using an implanted infusion pump (1980) (26)
p53 Nuclear overexpression may not be an independent prognostic marker in early colorectal cancer (1995) (25)
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease (2007) (25)
Transrectal ultrasonography of rectal carcinoma. (1990) (25)
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5‐fluorouracil and levamisole after resection of high risk colon cancer (1994) (24)
NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. (1996) (24)
A phase I trial of preoperative radiation, proctectomy, and endoanal reconstruction. (1990) (24)
The influence of timing of ketorolac administration on post-operative analgesic requirements following total abdominal hysterectomy. (1997) (24)
Intraoperative radiation therapy. (1986) (23)
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? (1996) (23)
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. (1992) (23)
Intraoperative brachytherapy alone for incomplete resected recurrent rectal cancer. (1991) (23)
Role of laparoscopy in the initial multimodality management of patients with near- obstructing rectal cancer (2007) (23)
Surgical considerations in patients with cancer of the colon and rectum. (1991) (22)
Anal squamous cell cancer nodal metastases: prognostic significance and therapeutic considerations. (1996) (22)
The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer. (2004) (22)
The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. (1997) (21)
Clustering of colorectal cancer in families of probands under 40 years of age (1996) (21)
Host immunity to growing sarcomas: Tumor‐specific serum inhibition of tumor‐specific cellular immunity (1973) (21)
Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision (2003) (21)
Clinicopathologic features in rectal cancer treated by local excision and postoperative radiation therapy. (1995) (21)
Transrectal ultrasonography and operative selection for early carcinoma of the rectum. (1994) (21)
Effect of ligation of variant hepatic arterial structures on the completeness of regional chemotherapy infusion. (1987) (20)
Preoperative evaluation of patients with primary colorectal cancer (1992) (20)
Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial. (1993) (20)
Specific inhibition of sarcoma‐specific cellular immunity by sera from patients with growing sarcomas (1973) (19)
Localization of radioiodinated monoclonal antibody in colorectal cancer. Initial dosimetry results. (1987) (19)
Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy (1985) (19)
Sphincter preservation in rectal sarcoma (1990) (19)
Predictive value of a negative computed tomographic scan in 100 patients with rectal carcinoma (1991) (19)
Basal-Rate Intravenous Insulin Infusion Compared to Conventional Insulin Treatment in Patients With Type II Diabetes: A Prospective Crossover Trial (1989) (18)
Adjuvant therapy of colorectal cancer. (1997) (18)
Palpable breast masses. The importance of preoperative mammography. (1981) (17)
Isolated spread of hepatic metastatic disease to a mediastinal lymph node (1991) (17)
Restorative or Preservative Operations in the Treatment of Rectal Cancer (1992) (17)
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. (1995) (17)
Proctectomy and coloanal reconstruction for rectal cancer (1990) (16)
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases (1998) (16)
Intraoperative electron beam radiation therapy boost in the treatment of recurrent rectal cancer (1980) (16)
Commentary on “The Applications of PET in Clinical Oncology” (1991) (15)
Society of Surgical Oncology: Statement on Genetic Testing for Cancer Susceptibility (1999) (15)
Treatment options for mid- and low-rectal cancers. (2000) (15)
Cancer Pain Relieved by Long-Term Epidural Morphine with Permanent Indwelling Systems for Self-Administration (1982) (14)
Adjuvant multimodality treatment of rectal cancer (1989) (14)
The adenoma carcinoma sequence in colorectal neoplasia. (1993) (13)
Cytotoxicity of human brain tumors by hematoporphyrin derivative. (1986) (13)
Conservative management of invasive rectal cancer: alternative to abdominoperineal resection. (1989) (13)
Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. (1983) (13)
65 Sphincter preservation with pre-operative radiation therapy (RT) and coloanal anastomosis: Long term follow-up (1997) (13)
Continuous canine epidural morphine analgesia with an implanted drug infusion pump. (1982) (12)
Preoperative radiation therapy for upper rectal cancer T3,T4/Nx: selectivity essential. (2012) (12)
Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110. (1991) (11)
Sphincter preservation of leiomyosarcoma of the rectum and anus with local excision and brachytherapy (1999) (11)
Results After Rectal Cancer Resection With In-Continuity Partial Vaginectomy and Total Mesorectal Excision (2003) (11)
Colon J-Pouch rectal reconstruction after total or subtotal proctectomy (1993) (10)
Total Mesorectal Excision with Pelvic Autonomic Nerve Preservation in the Operative Treatment of Rectal Carcinoma (1997) (10)
Blood Vessel Invasion in Colorectal Cancer—an Alternative to TNM Staging? (1999) (9)
67 High dose rate intra-operative radiation therapy (HDR-IORT) for locally advanced/unresectable primary and locally recurrent rectal cancer (1997) (9)
Radical surgery for rectal cancer: why we fail and rationale for current clinical trials of adjuvant therapy. (2000) (8)
Radiation therapy of rectal cancer (1982) (8)
Local excision and post-operative radiation therapy for rectal cancer (1993) (8)
Use of laparoscopic vascular stapler at laparotomy for colorectal cancer (1992) (7)
Continuous intravenous administration of ACTH. (1952) (7)
A phase I trial of hepatic artery fluorodeoxyuridine combined with systemic 5-fluorouracil for the treatment of metastases from colorectal cancer (1991) (7)
Colorectal cancer: Evolving concepts in diagnosis, treatment, and prevention (1999) (7)
Conservative management of rectal cancer with local excision and post-op radiation ± chemotherapy (1998) (6)
Acute toxicity of neoadjuvant bolus 5-FU/methotrexate and leucovorin rescue followed by continuous infusion 5-FU plus pre-operative radiation therapy for rectal cancer (1996) (6)
Simplified technique for placement of long term central venous silicone catheters. (1982) (6)
Analyses of protein kinase C isoform expression in a colorectal cancer liver metastasis model. (1995) (6)
High-Dose-Rate Intraoperative Irradiation (HDR-IORT) (1999) (6)
The Commission on Cancer of the American College of Surgeons: Restructuring to meet the demand for quality cancer care and cancer data (2002) (6)
Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. (2003) (5)
The role of surgery and chemoradiation therapy for cancer of the rectum. (1999) (5)
Aggressive versus conventional strategies in the treatment of rectal adenocarcinoma. (1996) (5)
Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer (2012) (5)
Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue (1987) (5)
Effect of tumor size on monoclonal antibody uptake in a metastatic model (1992) (4)
Implantable insulin infusion devices. (1982) (4)
Carcinoembryonic antigen release from colorectal cancer cells in tissue culture. (1979) (4)
Continuous intravenous ACTH infusion in small doses as a physiologic approach to treatment. (1954) (4)
Radiolocalization of monoclonal antibodies in hepatic metastases from human colon cancer in congenitally athymic mice. (1990) (4)
Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer (2004) (4)
Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in FAP Patients: Post-Hoc Analysis of a Randomized Clinical Trial. (2021) (4)
Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue. (1987) (4)
Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum. (1979) (4)
Adjuvant external beam and intraoperative radiation therapy in rectal cancer. (1989) (4)
What Is the Best Treatment for Stage IV Colorectal Cancer? (2005) (4)
Continuous Canine Epidural Morphine Analgesia with an Implanted Drug Infusion Pump (1982) (3)
Lysis of allogeneic tissue cultured colorectal cancer cells by blood group isoantibody in normal human serum. (1979) (3)
Radioimmunodetection of hepatic metastases from human colon cancer in nude mice with a gamma-detecting probe. (1990) (3)
Report of the Eighth International Symposium of the Foundation for Promotion of Cancer Research: basic and clinical research in colorectal cancer. (1995) (3)
[40] Implantable infusion pumps: Practical aspects (1985) (3)
Colorectal Cancer Surgical Practice Guidelines (1997) (3)
Management of invasive carcinoma in pedunculated colorectal polyps. (1989) (3)
1032 Preliminary results of pre-operative 5-FU, low dose leucovorin (LV), and concurrent radiation therapy (RT) for resectable T3 rectal cancer (1996) (3)
Total Rectal Resection (2000) (2)
Drug and enzyme targeting. Part A. (1985) (2)
Phase I trial of pre-operative combined radiation therapy, 5-FU, and low dose leucovorin for unresectable rectar cancer (1992) (2)
Sphincter preservation in rectal cancer. Technical considerations for coloanal anastomosis and J-pouch. (1998) (2)
401 – Efficacy and Safety of Combined Cpp-1X/Sulindac Vs Cpp-1X Or Sulindac Alone in Patients with Familial Adenomatous Polyposis: Results from a Double-Blind, Randomized Phase Iii Trial (2019) (2)
American Society of Colon and Rectal Surgeons 91st Annual Convention Podium and Poster abstracts (1992) (2)
Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma. [Efficacy and complications] (1980) (2)
CEA for monitoring colon cancer. (1994) (2)
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, (2016) (2)
HDR-IORT for Colorectal Cancer (1999) (2)
Computer-based inpatient medical record in colorectal surgery (2000) (2)
Adjuvant therapy in rectal cancer. (1992) (2)
Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases (1993) (2)
Extent of gross or microscopic perirectal fat invasion does not predict outcome in T3N0 rectal cancers (1998) (1)
Radioimmunolocation of metastases from adenocarcinoma of the colon: Using a hepatoma antibody (1990) (1)
Comparison of positron emission tomography and computed tomography in detection of recurrent and metastatic colorectal cancer (1997) (1)
Data on hepatic metastases (1992) (1)
MEDINFO at the MGH Oncology Data Research Center (1983) (1)
Colorectal cancer surgical practice guidelines. Colorectal Cancer Practice Guideline Committee. (1997) (1)
Serological evaluation of human brain tumors using a microradioisotopic staphylococcal protein a assay (1980) (1)
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer : A 14-year experience from a specialty service. Authors' reply (2005) (1)
Society of Surgical Oncology Presidential Address: Friendships, Partnerships, and Teams–Keys to Academic Success (2004) (1)
Has preoperative radiation therapy for resectable rectal cancer been proven effective? (1990) (1)
The effect of anesthetic technique on postoperative analgesia requirements. (1994) (1)
Implantable infusion pumps: practical aspects. (1985) (1)
Microradioisotopic techniques for the detection of antibody to adherent target cells in tissue culture. (1979) (1)
Society of Surgical Oncology: statement on genetic testing for cancer susceptibilty. Committee on Issues and Governmental Affairs of the Society of Surgical Oncology. (1999) (1)
Society of Surgical Oncology Practice Guidelines: Introductory Remarks (1997) (1)
Commentary (Cohen): Radiation Therapy for Resectable Colon Cancer (2006) (0)
Treatment of advanced colorectal cancer (1996) (0)
Adjuvant postoperative radiation therapy for resectable rectal cancer. (1991) (0)
Podium presentations (2014) (0)
93rd annual convention podium and poster abstracts (1994) (0)
A comparative study of surgery vs radioactive iodine-125 implantation in the treatment of pancreatic cancer (1978) (0)
Transanal Ultrasonically Activated Scalpel Technique for Local Excision of Rectal Tumors (2002) (0)
Society of Surgical Oncology Heritage Award–Honoring Charles M. Balch, M.D (2006) (0)
Technique for needle biopsy to confirm suspected hepatic metastases at laparotomy. (1988) (0)
Influence of variant arterial anatomy and surgical technique on technical complications in hepatic arterial infusion therapy (1998) (0)
Prior systemic chemotherapy does not alter outcome following major liver resection for metastatic colorectal cancer (2000) (0)
Radioimmunodetection of Hepatic MÃ©tastasesfrom Human Colon Cancer in Nude Mice with a Gamma-detecting Probe1 (2006) (0)
Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen (1984) (0)
B2 rectal cancer: Is radiation therapy for local control necessary? (1998) (0)
Commentary (Cohen): Are We Overtreating Some Patients With Rectal Cancer? (2004) (0)
SSO Practice Guidelines: Introductory Remarks (1997) (0)
Letters to the Editor (2003) (0)
The role of surgery and chemoradiation therapy for cancer of the rectum. (1999) (0)
Liver resection for metastatic colorectal cancer: Analysis of irresectability (1998) (0)
Management of colorectal cancer. (1990) (0)
Clinical assessment following preoperative combined modality therapy (CMT) for rectal carcinoma does not accurately predict pathologic response: A prospective analysis. (2004) (0)
100 High dose rate intraoperative brachytherapy for recurrent colorectal cancer (2000) (0)
Adjuvant therapy for colorectal cancer background and results of surgical resection (1997) (0)
Introduction of Dr. John M. Daly (2004) (0)
Rectus flap reconstruction decreases perineal wound complications following pelvic radiation and surgery: A cohort analysis (2004) (0)
The Sentinel Node in Colorectal Carcinoma (2002) (0)
S0266 Sulindac and Eflornithine Combination Delays the Need for Lower Gastrointestinal Surgery in Familial Adenomatous Polyposis: CPP FAP-310 Trial (2020) (0)
Colorectal neoplasia: surgery (1990) (0)
Thank you, Dr. Alfred S. Ketcham Educator, mentor and friend (2007) (0)
Current status of transcatheter management of neoplasms: A surgeon's view (2007) (0)
Clinical assessment following preoperative combined modality therapy (CMT) for rectal carcinoma does not accurately predict pathologic response: A prospective analysis (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alfred M. Cohen?

Alfred M. Cohen is affiliated with the following schools: